SEC Form 4 · accession 0001179110-15-010047
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
Jun 17, 2015
Accepted (ET)
Jun 19, 2015 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 17, 2015 | M | 784 | $12.58 | A | 111,164 | D | |
| Common Stock | Jun 17, 2015 | S | 784 | $23.00 | D | 110,380 | D | |
| Common Stock | Jun 18, 2015 | M | 14,966 | $12.58 | A | 125,346 | D | |
| Common Stock | Jun 18, 2015 | S | 14,966 | $23.00 | D | 110,380 | D | |
| Common Stock | Jun 18, 2015 | M | 9,563 | $13.26 | A | 119,943 | D | |
| Common Stock | Jun 18, 2015 | S | 9,563 | $23.00 | D | 110,380 | D | |
| Common Stock | Jun 18, 2015 | S | 11,000 | $24.90 | D | 99,380 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $12.58 | Jun 17, 2015 | M | 784 | D | Feb 19, 2014 | Feb 19, 2023 | Common Stock | 784 | 27,216 | D |
| Stock Option (Right to Buy) | $12.58 | Jun 18, 2015 | M | 14,966 | D | Feb 19, 2014 | Feb 19, 2023 | Common Stock | 14,966 | 12,250 | D |
| Stock Option (Right to Buy) | $13.26 | Jun 18, 2015 | M | 9,563 | D | Feb 22, 2015 | Feb 22, 2021 | Common Stock | 9,563 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2013.